Target silencing of disease-associated B-lymphocytes by chimeric molecules in SCID model of pristane-induced autoimmunity

Lupus

Volumn 19, Issue 11, 2010, Pages 1261-1271

  Dimitrova, I ^a   Gesheva, V ^a   Nikolova, K ^a   Mihaylova, N ^a   Todorov, T ^b   Nikolova, M ^c   Tchorbanov, Andrey I ^a  

^a INSTITUTE OF MICROBIOLOGY   (Bulgaria)

^b Sofia Medical School   (Bulgaria)

^c NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES   (Bulgaria)

Author keywords

autoantibodies; B cell suppression; chimeric molecules; Fc receptors; pristane models; SCID model; systemic lupus erythematosus

Indexed keywords

CHIMERIC ANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN RECEPTOR; PRISTANE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG TARGETING; FEMALE; IMMUNOTHERAPY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ENGINEERING; SCID MOUSE; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNITY; B-LYMPHOCYTES; CELL LINE; CYTOKINES; DNA; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; MICE, INBRED BALB C; MICE, SCID; RATS; RECEPTORS, ANTIGEN, B-CELL; RECEPTORS, IGG; RECOMBINANT FUSION PROTEINS; TERPENES;

EID: 78649744408     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310371153     Document Type: Article

References (35)

1. Kalsi JK, Martin AC, Hirabayashi Y.,et al. Functional and modelling studies of the binding of human monoclonal anti-DNA antibodies to DNA. Mol Immunol 1996 ; 33: 471-483.
2. Huston D., Steinberg A. Animal models of human systemic lupus erythematosus. Yale J Biol Med 1979 ; 52: 289-305. (Pubitemid 10250946)
3. Satoh M., Kumar A., Kanwar Y., Reeves W. Anti-nuclear antibody production and immune-complex glomerulonephritis in Balb/c mice treated with pristane. Proc Natl Acad Sci 1995 ; 92: 10934-10938.
4. Shaheen V., Satoh M., Richards HB, Yoshida H., Shaw M., Jennette C., Reeves W. Immunopathogenesis of Environmentally Induced Lupus in mice. Environ Health Perspect 1999 ; 107 (Suppl 5). 723-727.
5. Chae BS, Shin TY Immunoregulatory abnormalities of T cells and hyperreactivity of B cells in the in vitro immune response in pristane-induced lupus mice. Arch Pharm Res 2007 ; 30: 191-198.
6. Shlomchik MJ, Madaio MP, Ni D., Trounstein M., Huszar D. The role of B cells in lpr/lpr-induced autoimmunity. J Exp Med 1994 ; 180: 1295-1306.
7. Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999 ; 189: 1639-1648.
8. Ravetch JV, Lanier LL Immune inhibitory receptors. Science 2000 ; 290: 84-89.
9. Tarasenko T., Dean JA, Boland S. FcγRIIb as a modulator of autoimmune disease susceptibility. Autoimmunity 2007 ; 40: 409-417.
10. Wang YH, Diamond B. B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice. J Clin Invest 2008 ; 118: 2896-2907.
11. Sun Y., Fong KY, Chung MCM, Yoa ZJ Peptide mimicking antigenic and immunogenic epitope of double-stranded DNA in systemic lupus erythematosus. Intern Immunol 2001 ; 13: 223-232.
12. Putterman C., Deocharan B., Diamond B. Molecular analysis of the autoantibody response in peptide-induced autoimmunity. J Immunol 2000 ; 164: 2542-2549.
13. Tchorbanov A., Voynova E., Mihaylova N., Todorov T., Nikolova M., Yomtova V., et al. Selective silencing of DNA-specific B lymphocytes delays lupus activity in MRL/lpr mice. Eur J Immunol 2007 ; 37: 3587-3596.
14. Nikolova K., Tchorbanov A., Djoumerska-Alexieva I., Nikolova M., Vassilev T. Intravenous immunoglobulin up-regulates the expression of the inhibitory FcγIIB receptor on B cells. Immunol Cell Biol 2009 ; in press, DOI: 10.1038/icb.2009.36.
15. Mehod AR, Mant CT, Gera L., Stewart J. Preparative reversed-phase liquid chromatography of peptides. Isocratic tow-step elution system for high loads on analytical columns. J Chrom A 2002 ; 972: 87-99.
16. Bauminger S., Wilcheck M. The use of carbodiimides in the preparation of immunising conjugates. Meth Enzymol 1980 ; 70: 151-159.
17. Voynova EN, Tchorbanov AI, Todorov TA, Vassilev TL Breaking of tolerance to native DNA in nonautoimmune mice by immunization with natural protein/DNA complexes. Lupus 2005 ; 14: 543-550.
18. Mihaylova N., Voynova E., Tchorbanov A., Dolashka-Angelova P., Bayry J., Van Beeumen J., et al. Engagement of FcγIIb and CD22 inhibitory receptors suppresses the activity of targeted autoreactive B cells. Molec Imm 2009 ; doi:10.1016/j.molimm. 2009.01.013.
19. Satoh M., Richards HB, Shaheen VM, Yoshida H., Shaw M., Naim JO, et al. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin Exp Immunol 2000 ; 121: 399-405.
20. Satoh M., Reeves WH Induction of lupus-associated autoantibodies in Balb/c mice by intraperitoneal injection of pristane. J Exp Med 1994 ; 180: 2341-2346.
21. Kuroda Y., Akaogi J., Nacionales DC, Wasdo SC, Zsabo NJ, Reeves WH, Satoh M. Distinctive patterns of autoimmune response induced by different types of mineral oil. Toxicol Sci 2004 ; 78: 222-228.
22. Patten C., Bush K., Rioja I., Morgan R., Wooley P., Trill J., Life P. Characterization of pristane-induced arthritis, a murine model of chronic disease. Arthritis Rheumatism 2004 ; 50: 3334-3345.
23. Ahuja A., Shupe J., Dunn R., Kashgarian M., Kehry M., Shlomchik M. Depletion of B cells in murine lupus: Efficacy and resistance. J Immunol 2007 ; 179: 3351-3361.
24. Lund F. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 2008 ; 20: 332-338.
25. Bouaziz JD, Yanada K., Venturi GM, Wang Y., Tisch R., Poe J., Tedder T. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci U S A 2007 ; 104: 20878-20883.
26. Dörner T., Kaufmann J., Wegener W., Teoh N., Goldenberg D., Burmester G. Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus. Arthritis Res Therapy 2006 ; R74.
27. Daëron M., Lesourne R. Negative signaling in Fc receptor complexes. Adv Immunol 2006 ; 89: 39-86.
28. Ravech J., Lanier L. Immune inhibitory receptors. Science 2000 ; 290: 84-89.
29. Nimmerjahn F., Ravetch JV Fcgamma receptors: old friends and new family members. Immunity 2006 ; 24: 19-28.
30. Kaneko Y., Nimmerjahn F., Madaio MP, Ravetch JV Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J Exp Med 2006 ; 203: 789-797.
31. Duchosal M., McConahey P., Robinson C., Dixon F. Transfer of human systemic lupus erythematosus in severe combined immunodeficient (SCID) mice. J Exp Med 1990 ; 172: 985-988.
32. Macchiarini F., Manz M., Palucka K., Shultz L. Humanized mice: are we there yet? J Exp Med 2005 202: 1307-1311.
33. Clynes R., Calvani N., Crocer BP, Richards HB Modulation of the immune response in pristine-induced lupus by expression of activation and inhibitory Fc receptors. Clin Exp Immunol 2005 ; 141: 230-237.
34. Mizutani A., Shaheen VM, Yoshida H., Akaogi J., Kuroda Y., Nacionales DC, et al. Pristane-induced autoimmunity in germ-free mice. Clin Immunol 2005 ; 114: 110-118.
35. Hoyer BF, Moser K., Hauser AE, Peddinghaus A., Voigt C., Eilat D., et al. Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice. J Exp Med 2004 ; 199: 1577-1584.